Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed |
|---|---|---|
|
Coherus Oncology, Inc.
13G/A
Amendment 2
CHRS · 19249H103
|
8.3% |
5/15/2026
Event 3/31/2026
|
|
Coherus Oncology, Inc.
13G/A
Amendment 1
CHRS · 19249H103
|
Checked 5% or less
|
5/11/2026
Event 2/5/2026
|
|
Coherus Oncology, Inc.
13G
CHRS · 19249H103
|
6.5% |
2/5/2026
Event 2/5/2026
|